Michael Zapor, MD, PhD, CTropMed, CPEMonkeypox: a brief overview (7 July 2022)As the COVID-19 pandemic crosses the two-and-a-half-year mark, another unrelated virus is now garnering international attention and…Jul 7, 2022Jul 7, 2022
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: Pursuit of a universal coronavirus vaccine (4 January 2022)The emergence of vaccine evasive SARS-CoV-2 variants, coupled with previous coronavirus outbreaks caused by severe acute respiratory…Jan 4, 2022Jan 4, 2022
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: A look at the data supporting COVID vaccination of 5–11-year-old children (8 November…On 29 October 2021, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for use of the Pfizer-BioNTech…Nov 8, 20211Nov 8, 20211
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: Addressing some common concerns contributing to COVID-19 vaccine hesitancy (14 September…Considerable time has passed since I published my last COVID-19-themed post, a delay due in large part to my professional obligations as a…Sep 13, 2021Sep 13, 2021
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: A musing for the detractors of masking and vaccination (9 April 2021)There is a popular trend on social media to portray people who refuse to wear masks or get the COVID vaccine as brave non-conformists, and…Apr 9, 2021Apr 9, 2021
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: Synopsis of three notable SARS-CoV-2 variants of concern (5 March 2021)Three COVID-19 vaccines currently have emergency use authorization (EUA) from the Food and Drug Administration (FDA). These include…Mar 3, 20211Mar 3, 20211
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: Synopsis of the available and likely soon to be available COVID-19 vaccines (9 February…In several prior posts, I describe the conventional sequence of vaccine development (i.e. pre-clinical research, Phase 1, 2, and 3…Feb 9, 20211Feb 9, 20211
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: The Russian COVID-19 Vaccine Candidate (6 September 2020)In several prior posts, I describe the research underway to produce a vaccine against SARS-CoV-2, the virus that causes COVID-19 (1,2)…Sep 6, 2020Sep 6, 2020
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: Hydroxychloroquine Reviewed (15 August 2020)One of the hot button topics being discussed nowadays is the utility of hydroxychloroquine in the treatment of patients infected with…Aug 9, 20201Aug 9, 20201
Michael Zapor, MD, PhD, CTropMed, CPECOVID-19: The Dilemma of Reopening Schools (1 August 2020)One of the most pressing COVID-19-related questions currently being debated on both the local and national level is whether schools should…Jul 30, 2020Jul 30, 2020
